GlassScriptPhysician profile
Ayesha R Butt
NPI 1407197338
$5,208.87
in general payments reported to CMS, 2019-2025
20 companies · $941 in 2025
The $941 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $221 · 2021: $528 · 2022: $571 · 2023: $1,822 · 2024: $848 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,572 · Travel and Lodging: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.24 |
| Travel and Lodging | $1,039.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,585.18 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,447.77 | 2019-2025 | Dailies Total1, Total30, Precision7 |
| Oyster Point Pharma, INC. | $219.44 | 2022-2025 | Tyrvaya, Ryzumvi |
| Optos, INC. | $138.51 | 2020-2021 | |
| Coopervision INC. | $100.51 | 2019-2024 | Onefit Contact Lens, Myday Contact Lens |
| Sight Sciences, INC. | $95.50 | 2020-2024 | Tearcare System |
| Shire North American Group INC | $89.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $85.38 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $79.16 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $51.26 | 2022 | |
| Allergan, INC. | $48.03 | 2020 | |
| Bausch & Lomb Americas INC. | $46.39 | 2023 | Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.09 | 2019-2021 | |
| Biotissue Holdings INC. | $40.60 | 2022-2023 | |
| Dompe US, INC. | $29.73 | 2024 | Oxervate |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $29.49 | 2019 | |
| Thea Pharma INC. | $24.08 | 2023 | Iyuzeh |
| Synergeyes, INC. | $18.57 | 2022 | |
| Harrow Eye, LLC | $17.59 | 2024 | Vevye |
| Rxsight INC | $17.32 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayesha Butt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.